Glenmark Pharmaceuticals | Zee News

Advertisement

NewsGlenmark Pharmaceuticals

Glenmark Pharmaceuticals News

Glenmark Pharmaceuticals

17 Aug 2020

Glenmark Pharmaceuticals close over 1% higher, trims most of early gains

Glenmark stocks closed 1.16 per cent higher at Rs 480.90 on BSE. On the NSE, it closed with a gain of 1.48 per cent at Rs 482.75. During the day, the scrip had jumped 6.96 per cent to Rs 508.50 on the BSE.

Glenmark Pharmaceuticals

12 Aug 2016

Glenmark Pharmaceuticals' Q1 net profit up 24% at Rs 227 cr

Glenmark Pharmaceuticals on Friday reported a 23.96 percent rise in consolidated net profit to Rs 226.78 crore for the first quarter ended June 30, 2016, mainly on account of robust sales.

Glenmark Pharmaceuticals

28 Mar 2016

Glenmark gets two ANDA approvals from USFDA

Glenmark Pharmaceuticals has received final approval from the US health regulator USFDA for oral contraceptives and leukemia treatment injection.

Glenmark Pharmaceuticals

24 Dec 2015

Glenmark seeks shareholders' nod to raise up to $500 million

Glenmark Pharmaceuticals seeks shareholders' approval to raise up to USD 500 million (around Rs 3,300 crore) by issue of securities to fund its expansion plans, including setting up of new manufacturing facilities.

Glenmark Pharmaceuticals

22 Dec 2015

Glenmark gets USFDA final nod for anti-bacterial drug

Glenmark Pharmaceuticals has received the final nod from the US health regulator for a generic version of anti-bacterial drug Zyvox.

30 Oct 2015

Corporate Earnings: Top gainers and losers in Q2 results announced today

The major gainers and losers announcing corporate earnings on Friday:

Glenmark Pharmaceuticals

30 Oct 2015

Glenmark Pharma scrip gains 6% post Q2 earnings

Shares of Glenmark Pharmaceuticals today climbed 6 per cent after the company reported 20 per cent increase in consolidated net profit for the second quarter ended September 30.

Glenmark Pharmaceuticals

29 Oct 2015

Glenmark Q2 net up 20% at Rs 198 crore

Glenmark Pharmaceuticals Thursday reported 19.81 percent increase in consolidated net profit to Rs 197.78 crore for the second quarter ended September 30, driven by good growth in India, US and Europe.

Glenmark Pharmaceuticals

08 Oct 2015

Glenmark evaluating legal options over diabetes drugs setback

Drug firm Glenmark Pharmaceuticals today said it is evaluating legal options after the Delhi High Court restrained it from manufacturing and selling generic version of MSD's anti-diabetes medicines Januvia and Janumet.

Glenmark Pharmaceuticals

07 Oct 2015

Blow to Glenmark: HC restrains it from making anti-diabetes drugs

In a blow to Indian drug firm Glenmark Pharmaceuticals, Delhi High Court Wednesday restrained it from making, selling, advertising, distributing or exporting its anti-diabetes drugs Zita and Zita-Met on the ground that it violated the patent of US pharma major Merck Sharp and Dohme (MSD).

Glenmark Pharmaceuticals

22 Sep 2015

Glenmark Pharma eyes US biz to be strong growth driver

Glenmark Pharmaceuticals Tuesday said it is looking at strong growth in the US market and developing a pipeline of innovative products to offset weakness in emerging markets.

India drugmaker

03 Sep 2015

India drugmaker stocks exception in Asian rout

In Mumbai trading so far this year, Lupin Ltd has climbed 32 percent, Dr. Reddy`s 31 percent, Glenmark Pharmaceuticals 42 percent and Wockhardt 29 percent.

Glenmark Pharmaceuticals

19 Aug 2015

Glenmark receives USFDA nod for oral contraceptive drug

"Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (USFDA) for Drospirenone and Ethinyl Estradiol tablets USP, 3 mg/0.02 mg," the company said in a BSE filing.

Glenmark Pharmaceuticals

30 Jul 2015

Glenmark Q1 net up 3.29% at Rs 191 crore

Glenmark Pharmaceuticals on Thursday posted 3.29 percent rise in consolidated net profit at Rs 190.93 crore for the first quarter ended June 30, driven by sales in domestic as well as overseas markets.

Glenmark Pharmaceuticals

15 Jun 2015

Glenmark gets USFDA final nod for contraceptive tablets

Glenmark Pharmaceuticals has received final nod from the US health regulator for generic oral contraceptive Levonorgestrel/Ethinyl Estradiol tablets and plans to commence shipping of the product immediately.

Glenmark Pharmaceuticals

11 Jun 2015

Glenmark gets final USFDA nod for psoriasis cream

Glenmark Pharma was today trading at Rs 867.35 in the afternoon trade on BSE, up 1.19 percent.

Glenmark Pharmaceuticals

19 May 2015

Glenmark issues over 1 cr shares to Aranda, raises Rs 945 cr

Glenmark Pharmaceuticals has raised Rs 945 crore by issuing over 1 crore shares to Aranda Investments, an indirect subsidiary of Temasek Holdings.

Glenmark Pharmaceuticals

19 May 2015

FIIs can now invest up to 49% in Glenmark Pharma

The Reserve Bank Tuesday allowed foreign institutional investors (FIIs) to buy up to 49 percent stake in homegrown drug major Glenmark Pharmaceuticals.

Glenmark Pharmaceuticals

15 May 2015

Supreme Court bars Glenmark from selling Merck drug copies

Glenmark is barred from producing sitagliptin until the next hearing on the case, the order said.

Glenmark Pharmaceuticals

04 May 2015

Glenmark gets tentative USFDA nod for generic psoriasis cream

The product is the therapeutic equivalent of Danish pharma firm Leo Pharma A/S Dovonex's topical cream of the same strength.

Loading...

NEWS ON ONE CLICK